Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by studpuppyon Mar 04, 2011 10:32am
216 Views
Post# 18231602

RE: Spoke to the Stifel Analyst today

RE: Spoke to the Stifel Analyst todayRusty no one here doubts the future of Thera,we all know we have a winner in our hands in the LONG TERM , and most of us have been here for a long time, the thing that is pis&&ing off everybody and maybe including yourself is the way management a.k.a HUSS is handling the situation since he came on board, the company was HANDED to him on  A GOLD PLATTER and we are hoping he doesn`t drop the ball and so far no one is impressed with him, i as shareholder am certainly not happy, anyway for the short term holders you will get a chance to get out with some profit soon, as soon as we get listed on the nasdaq i say within a month they will do a nice pump and dump and that will be your chance to bail out until then its not worth selling at these prices just hold on a bit more...
glta regards stud
Bullboard Posts